Advertisement

The effect of statins on the occurrence of peptic ulcer

  • Anning Feng
    Affiliations
    Division of Cardiology, Cheng Hisn General Hospital, Taipei, Taiwan

    Nation Yang-Ming University, Taipei, Taiwan
    Search for articles by this author
  • Eric Chuang
    Affiliations
    UC Berkeley Mishler Lab Undergraduate Researcher, Intended B.S. Molecular and Cell Biology, University of CA, Berkeley, USA
    Search for articles by this author
  • Szu-Hsien Wu
    Affiliations
    Department of Physical Medicine and Rehabilitation, Veterans General Hospital Taipei, Taipei, Taiwan

    National Yang-Ming University, Taipei, Taiwan
    Search for articles by this author
  • Jia-Chi Wang
    Affiliations
    Department of Physical Medicine and Rehabilitation, Veterans General Hospital Taipei, Taipei, Taiwan

    National Yang-Ming University, Taipei, Taiwan
    Search for articles by this author
  • Shih-Ni Chang
    Affiliations
    Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan
    Search for articles by this author
  • Cheng-Li Lin
    Affiliations
    Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan

    College of Medicine, China Medical University, Taichung, Taiwan
    Search for articles by this author
  • Chia-Hung Kao
    Correspondence
    Corresponding author at: Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, No. 2, Yuh-Der Road, Taichung 404, Taiwan. Tel.: +886 4 22052121x7412; fax: +886 4 22336174.
    Affiliations
    Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan

    Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
    Search for articles by this author

      Highlights

      • The statin cohort had a significant lower risk of PUD for all age group.
      • The concomitant use of aspirin and/or NSAIDs had higher incidence of PUD.
      • High-dose groups (≧575 DDD) exhibited significantly decreased risk.

      Abstract

      Background

      This study was to determine the association between the use of statins and the occurrence of peptic ulcer diseases (PUD).

      Methods

      Using the National Health Insurance Research Database to conduct a population-based cohort study. We identified 48,562 patients who were newly diagnosed with hyperlipidemia during the period of 1998 to 2011 and who were divided into two groups based on their use of statins. The non-statin cohort (without statin treatment, 24,139 patients) were 1:1 frequency matched with sex, age, year of diagnosis of hyperlipidemia and index-year to the statin cohort (24,423 patients). The relative risk of patients with and without statins treatment on the occurrence of PUD and concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin were analyzed using the univariable and multivariable Cox proportional hazards regression model.

      Results

      The incidence of PUD increased with age in both cohorts and female had a higher occurrence rate than male in both cohorts. Compared with the non-statin cohort, the statin cohort was associated with a significant lower risk of PUD for all age group. The concomitant use of aspirin and/or NSAIDs had higher incidence of PUD than those without in both cohorts. Analyzing the cumulative defined daily dose (DDD) of statins indicated that high-dose groups (≧575 DDD) exhibited significantly decreased risk compared with non-statin users.

      Conclusion

      The results of the present study indicated that statins might be associated with the protection of peptic ulcer in a dose-respondent manner.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Goldstein J.L.
        • Brown M.S.
        Regulation of the mevalonate pathway.
        Nature. 1990; 343: 425-430
        • Levine G.N.
        • Keaney J.F.
        • Vita J.A.
        Cholesterol reduction in cardiovascular disease.
        N. Engl. J. Med. 1995; 332: 512-521
        • Wassmann S.
        • Laufs U.
        • Bäumer A.T.
        • Müller K.
        • Ahlbory K.
        • Linz W.
        • et al.
        HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
        Hypertension. 2001; 37: 1450-1457
        • Vaughan C.J.
        • Murphy M.B.
        • Buckley B.M.
        Statins do more than just lower cholesterol.
        Lancet. 1996; 348: 1079-1082
        • Chen P.S.
        • Cheng C.L.
        • Chang Y.C.
        • Kao Yang Y.H.
        • Yeh P.S.
        • Li Y.H.
        Early statin therapy in patients with acute intracerebral hemorrhage without prior statin use.
        Eur. J. Neurol. Jan 26 2015; ([Epub ahead of print])https://doi.org/10.1111/ene.12649
        • Chatterjee S.
        • Krishnamoorthy P.
        • Ranjan P.
        • Roy A.
        • Chakraborty A.
        • Sabharwal M.S.
        • et al.
        Statins and cognitive function: an updated review.
        Curr. Cardiol. Rep. 2015; 17: 559
        • Stegman B.
        • Puri R.
        • Shao M.
        • Nicholls S.J.
        Response to Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.
        Diabetes Care. 2014; 37: 3114-3120
        • Chuang C.S.
        • Lin C.L.
        • Lin M.C.
        • Sung F.C.
        • Kao C.H.
        Decreased prevalence of dementia associated with statins: a national population-based study.
        Eur. J. Neurol. Mar 18 2014; ([Epub ahead of print])https://doi.org/10.1111/ene.12402
        • Laufs U.
        • La Fata V.
        • Plutzky J.
        • Liao J.K.
        Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors.
        Circulation. 1998; 97: 1129-1135
        • Hernandez-Perera O.
        • Perez-Sala D.
        • Navarro-Antolin J.
        • Sanchez-Pascuala R.
        • Hernandez G.
        • Diaz C.
        • et al.
        Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atrovastatin and simvastatin, on the expression of endothelial-1 and endothelial nitric oxide synthase in vascular endothelial cells.
        J. Clin. Invest. 1998; 101: 2711-2719
        • Weis M.
        • Heeschen C.
        • Glassford A.J.
        • Cooke J.P.
        Statins have biphasic effects on angiogenesis.
        Circulation. 2002; 105: 739-745
        • Nagasue T.
        • Nakamura S.
        • Kochi S.
        • Kurahara K.
        • Yaita H.
        • Kawasaki K.
        • Fuchigami T.
        Time trends of the impact of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs on peptic ulcer bleeding in Japanese patients.
        Digestion. 2015; 91 ([Epub 2015 Jan 20]): 37-41https://doi.org/10.1159/000368810
        • Tan H.J.
        • Goh K.L.
        Changing epidemiology of Helicobacter pylori in Asia.
        J. Dig. Dis. 2008; 9: 186-189
        • Yazbek P.B.
        • Trindade A.B.
        • Chin C.M.
        • Santos J.L.D.
        Challenges to the treatment and new perspectives for the eradication of Helicobactor pylori.
        Dig. Dis. Sci. May 22 2015; ([Epub ahead of print])
        • Badillo R.
        • Schmidt R.
        • Mortensen E.M.
        • Christopher R.F.
        • Mansi I.
        Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching.
        Pharmacoepidemiol. Drug Saf. 2015; https://doi.org/10.1002/pds.3817
        • El II, H.
        • Mourad F.H.
        • Shabb N.S.
        • Barada K.A.
        Atorvastatin-induced severe gastric ulceration: a case report.
        World J. Gastroenterol. 2005; 11: 3159-3160
        • Schelleman H.
        • Bilker W.B.
        • Brensinger C.M.
        • Wan F.
        • Yang Y.X.
        • Hennessy S.
        Fibrate/statin initiation in warfarin users and gastrointestinal bleeding risk.
        Am. J. Med. 2010; 123: 151-157
        • Chatterjee S.
        • Chatterjee A.
        • Roy S.
        • Bera B.
        • Bandyopadhyay S.K.
        L-Theanine healed NSAID-induced gastric ulcer by modulating pro/antioxidant balance in gastric ulcer margin.
        J. Nat. Med. 2014; 68: 699-708
        • Mei X.T.
        • Xu D.H.
        • Xu S.K.
        • Zheng Y.P.
        • Xu S.B.
        Zinc(II)-curcumin accelerates the healing of acetic acid-induced chronic gastric ulcers in rats by decreasing oxidative stress and downregulation of matrix metalloproteinase-9.
        Food Chem. Toxicol. 2013; 60: 448-454
        • Yadav S.K.
        • Adhikary B.
        • Bandyopadhyay S.K.
        • Chattopadhyay S.
        Inhibition of TNF-α, and NF-κB and JNK pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy.
        Biochim. Biophys. Acta. 1830; 2013: 3776-3786
        • Özbakiş-Dengız G.
        • Hekımoğlu A.
        • Kandemır N.
        • Kurcer Z.
        Effects of statins in an indomethacin-induced gastric injury model in rats.
        Turk. J. Gastroenterol. 2012; 23: 456-462
        • Baraka A.M.
        • Guemei A.
        • Gawad H.A.
        Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats.
        Biochem. Pharmacol. 2010; 79: 1634-1639
        • Ghaisas M.M.
        • Dandawate P.R.
        • Zawar S.A.
        • Ahire Y.S.
        • Gandhi S.P.
        Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.
        Inflammopharmacology. 2010; 18: 169-177
        • Heeba G.H.
        • Hassan M.K.
        • Amin R.S.
        Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins.
        Eur. J. Pharmacol. 2009; 607: 188-193
        • Tariq M.
        • Khan H.A.
        • Elfaki I.
        • Arshaduddin M.
        • Al Moutaery M.
        • Al Rayes H.
        • et al.
        Gastric antisecretory and antiulcer effects of simvastatin in rats.
        J. Gastroenterol. Hepatol. 2007; 22: 2316-2323
        • Douketis J.D.
        • Melo M.
        • Bell C.M.
        • Mamdani M.M.
        Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?.
        Am. J. Med. 2007; 120: 369.e9-369.e14
        • Chen P.S.
        • Cheng C.L.
        • Chang Y.C.
        • Kao Yang Y.H.
        • Yeh P.S.
        • Li Y.H.
        Early statin therapy in patients with acute intracerebral hemorrhage without prior statin use.
        Eur. J. Neurol. Jan 26 2015; ([Epub ahead of print])https://doi.org/10.1111/ene.12649
        • Castilla-Guerra L.
        • Fernandez-Moreno
        Do persons with stroke benefit from statin-fibrate combination therapy?.
        Eur. J. Intern. Med. Mar 2015; 26 (S0953-6205(15)00023-0): 148-149
        • Williams P.T.
        Lower risk of Alzheimer's disease mortality with exercise, statin, and fruit intake.
        J. Alzheimers Dis. 2015; 44: 1121-1129
        • Li Q.
        • Huang P.
        • He Q.C.
        • Lin Q.Z.
        • Wu J.
        • Yin R.X.
        Association between the CETP polymorphisms and the risk of Alzheimer's disease, carotid atherosclerosis, longevity, and the efficacy of statin therapy.
        Neurobiol. Aging. 2014; 35: e13-e23
        • Lv S.
        • Liu Y.
        • Zou Z.
        • Li F.
        • Zhao S.
        • Shi R.
        • et al.
        The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis.
        Clin. Exp. Rheumatol. 2015; 33: 69-76
        • Pereira M.C.
        • Cardoso P.R.
        • Da Rocha L.F.
        • Jr Rêgo M.J.
        • Gonçalves S.M.
        • Santos F.A.
        • et al.
        Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis.
        Inflamm. Res. 2014; 63: 309-315
        • Oling M.
        • Odongo J.
        • Kituuka O.
        • Galukande M.
        Prevalence of Helicobacter pylori in dyspeptic patients at a tertiary hospital in a low resource setting.
        BMC Res. Notes. 2015; 8: 256https://doi.org/10.1186/s13104-015-1184-y
        • Shiotani A.
        • Murao T.
        • Sakakibara T.
        • Tarumi K.
        • Manabe N.
        • Kamada T.
        • et al.
        Association of SLCO1B1 1b with peptic ulcer amongst Japanese patients taking low-dose aspirin.
        Dig. Liver Dis. 2012; 44: 201-205
        • Derogar M.
        • Sandblom G.
        • Lundell L.
        • Orsini N.
        • Bottai M.
        • Sadr-Azodi Lu.Y.
        • O
        Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increase risk of death and acute cardiovascular events.
        Clin. Gastroenterol. Hepatol. 2013; 11: 38-42